Microcap Ledger Picard Medical, Inc. $PMI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- NYSE American
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Tucson, AZ
- Fiscal year end
- December 31
- Shares outstanding
- 2,338,634 [10-Q 2026-08-19]
What the company doesAI summary of filing
Picard Medical, Inc. is a holding company that owns SynCardia Systems, LLC, a medical device manufacturer. SynCardia manufactures and sells the SynCardia Total Artificial Heart (TAH), the only FDA and Health Canada approved total artificial heart for commercial use, which fully replaces the function of a failing human heart in patients with end-stage biventricular heart failure. The company generates revenue through sales of the SynCardia TAH system and related components to hospitals, which are reimbursed primarily through Medicare, Medicaid, and private insurers under diagnosis-related group codes ranging from approximately $187,000 to $482,000 per implantation procedure. The company is revenue-generating, with more than 2,100 SynCardia TAHs implanted globally to date, and is pursuing development of next-generation technologies including a fully implantable artificial heart called the Emperor TAH and next-generation driver systems. [10-K 2026-03-30]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $4.10M | −$13.28M | −$5.15M | $38.0K | [10-Q 2026-08-19] |
| FY ended Dec 2025 | $4.94M | −$27.00M | −$15.67M | $7.45M | [S-1/A 2026-05-01] |
| FY ended Dec 2024 | $4.39M | −$21.05M | −$11.87M | $96.0K | [S-1/A 2026-05-01] |
- Quarterly cash burn
- −$2.58M
- Cash runway Estimate
- ~0 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-09-11 | 73,701,176 | [10-Q 2025-09-12] |
| 2025-11-10 | 73,701,176 | [10-Q 2025-11-14] |
| 2026-03-23 | 75,178,535 | [10-K 2026-03-30] |
| 2026-05-11 | 92,349,845 | [10-Q 2026-05-15] |
| 2026-08-18 | 2,338,634 | [10-Q 2026-08-19] |
- Shelf registration
- S-1 filed 2026-05-20; declared effective 2026-05-29 [S-1 2026-05-20]
Listing status
Current status: 3 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-27. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-27] |
| 2026-05-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-21] |
| 2026-05-11 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-11] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | 8-K | New financial obligation; Unregistered sale of equity |
| 2026-08-20 | 8-K | Regulation FD disclosure |
| 2026-08-19 | 10-Q | Quarterly report |
| 2026-08-17 | NT 10-Q | Notice of late quarterly report |
| 2026-08-07 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-27 | 8-K | Listing notice or transfer; Other events |
| 2026-07-22 | 8-K | Charter, bylaws or fiscal year change; Other events |
| 2026-07-21 | 8-K | Shareholder vote results |
| 2026-07-13 | 8-K | Other events |
| 2026-07-07 | 8-K | Director or officer change |
| 2026-07-02 | 8-K | Other events |
| 2026-07-02 | 8-K | Other events |
Alerts for $PMI
Email me when Picard Medical, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.